If CBD is to be regulated as a drug, then so should honey. That was one of the views put forward as industry members and the US Food and Drug Administration (FDA) butted heads at a meeting of the FDA Science Board public advisory committee.
Sibyl Swift, vice president for scientific and regulatory affairs of North Carolina-based company cbdMD, said foods such as honey were known to have biochemical and physiological effects on cells, tissues, and organs, otherwise known as pharmacological effects. She argued that honey has been found to cause pharmacological harm but is not questioned in the same way that CBD is.